The Relationship of Osteoprotegerin with Cardiovascular Risk Factors in Women with and Without Polycystic Ovary Syndrome
Aim:In this study, we aimed to compare osteoprotegerin (OPG) levels in patients with and without polycystic ovary syndrome (PCOS) and to investigate the correlation between OPG levels and cardiovascular risk factors.Methods:A total of 49 patients with PCOS and 31 age- and body mass index-matched hea...
Main Authors: | Gültekin Adanaş Aydın, Hilal Gülsüm Turan Özsoy |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2020-06-01
|
Series: | Haseki Tıp Bülteni |
Subjects: | |
Online Access: |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/the-relationship-of-osteoprotegerin-with-cardiovas/38675
|
Similar Items
-
Evaluation of serum omentin, osteoprotegerin and malondialdehyde levels in women with polycystic ovary syndrome: a prospective case-control study
by: Murat Levent Dereli, et al.
Published: (2016-03-01) -
Osteoprotegerin is a new marker of cardiovascular diseases
by: A F Verbovoy, et al.
Published: (2017-04-01) -
Study of early atherosclerotic markers in women with polycystic ovary syndrome
by: Ritu Karoli, et al.
Published: (2012-01-01) -
Research progress of oxidative stress increasing the risk of cardiovascular disease of polycystic ovary syndrome patients
by: LI Huan-huan, ZHANG Yu-qi, LYU Hai-hong
Published: (2022-12-01) -
Cardiovascular disease risk in young women with polycystic ovary syndrome
by: A Guleria, et al.
Published: (2012-01-01)